Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $2,240,750 (100.0% shares, 0.0% debt)

Holdings (10)

MRNA Moderna Inc 69.9%
Value ($000) $1,565,739 Shares 12,886,743 Est. Cost $16.43 Unrealized +711.7%
SANA Sana Biotechnology Inc 8.9%
Value ($000) $198,409 Shares 33,290,018 Est. Cost $32.56 Unrealized -82.3%
— Omega Therapeutics Inc 7.3%
Value ($000) $163,663 Shares 29,225,579 Est. Cost $17.39 Unrealized —
— Seres Therapeutics Inc 4.9%
Value ($000) $110,731 Shares 23,117,045 Est. Cost $7.75 Unrealized —
FHTX Foghorn Therapeutics Inc 4.0%
Value ($000) $89,226 Shares 12,674,120 Est. Cost $19.16 Unrealized -63.5%
DNLI Denali Therapeutics Inc 3.5%
Value ($000) $77,315 Shares 2,619,968 Est. Cost $17.97 Unrealized +56.5%
— Sigilon Therapeutics Inc 0.8%
Value ($000) $17,957 Shares 797,720 Est. Cost $22.51 Unrealized —
EVLO Evelo Biosciences Inc 0.4%
Value ($000) $8,194 Shares 2,521,369 Est. Cost $2.97 Unrealized 0.0%
— Axcella Health Inc 0.3%
Value ($000) $6,386 Shares 29,251,545 Est. Cost $4.17 Unrealized —
SYRS Syros Pharmaceuticals Inc 0.1%
Value ($000) $3,131 Shares 993,848 Est. Cost $8.12 Unrealized -60.4%